[A study on oxidative DNA damage and lipid peroxidation in patients with tuberculous pleurisy]

Wei Liu1, Xiao-ju Liu, Qin Yu

  • 1Department of Respiratory Diseases, First Affiliated Hospital of Lanzhou Medical College, Lanzhou 730000, China.

Abstract

Insights

Tuberculous pleurisy patients exhibit oxidative stress, with higher DNA damage and lipid peroxidation. Their total antioxidative capacity is inadequate, especially within the pleural cavity, indicating an imbalance.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Context:

  • Tuberculous pleurisy is an inflammatory condition affecting the pleura.
  • Oxidative stress plays a role in various inflammatory diseases.
  • Understanding oxidative stress markers can aid in disease management.

Purpose:

  • To investigate mononuclear cell oxidative DNA damage and lipid peroxidation in tuberculous pleurisy.
  • To assess total antioxidative capacity (TAC) in patients with tuberculous pleurisy.
  • To correlate oxidative stress markers with disease status.

Summary:

  • Patients with tuberculous pleurisy showed significantly higher mononuclear cell DNA damage (comet percentage) in pleural effusion compared to peripheral blood.
  • Elevated levels of malondialdehyde (MDA), a marker of lipid peroxidation, were observed in patients' peripheral blood.
  • Total antioxidative capacity (TAC) was significantly lower in both pleural effusion and blood plasma of patients compared to healthy controls, with a particularly pronounced reduction in the pleural cavity.

Impact:

  • The findings reveal an oxidation-antioxidation imbalance, indicative of oxidative stress, in tuberculous pleurisy.
  • Inadequate total antioxidative capacity, especially in the pleural cavity, is a key feature of the disease.
  • This study highlights the potential of oxidative stress markers for understanding the pathophysiology of tuberculous pleurisy.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation